Researchers at McMaster University have developed a rapid and inexpensive method to produce “mechanically robust” cell sheets ...

Serina Therapeutics, Inc. ('Serina” or the 'Company') (NYSE American: SER), a clinical-stage biotechnology company advancing its lead Investigational New Drug ('IND') candidate, SER-252, for advanced ...

Biphenomycins, natural products derived from bacteria, show excellent antimicrobial activity, but have long remained out of ...

This is the third of four planned U.S. manufacturing sites the pharmaceutical giant has unveiled this year, set to bring 450 ...

Final 2025 global cohort onboarding, with applications now open for 2026WILMINGTON, Mass.--(BUSINESS WIRE)--$CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the ...

Eupraxia Pharmaceuticals , a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed ...

NewcelX ( ($NCEL) ) has issued an announcement. On December 11, 2025, NewcelX Ltd. announced the publication of a patent application in China for ...

Charles River Laboratories International Inc. has announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP).

Detailed price information for Sana Biotechnology Inc (SANA-Q) from The Globe and Mail including charting and trades.

Bartronics India Limited has marked a significant milestone in its growth trajectory with the approval and incorporation of ...

NewcelX Ltd. , a next-generation biotechnology company developing advanced cell-therapy and neuroscience-driven therapeutics, today announced the publication of a major international patent ...

The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...